Regulation of Cytoplasmic Lipid Droplet Mobilization in Intestinal Enterocyte
肠肠上皮细胞胞质脂滴动员的调节
基本信息
- 批准号:RGPIN-2021-03608
- 负责人:
- 金额:$ 2.7万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2022
- 资助国家:加拿大
- 起止时间:2022-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Most mammals use dietary fats as their major energy source. Handling of dietary fats in the gut plays crucial roles in whole-body energy homeostasis and physiology, with far-reaching impacts on other parts of the body and the overall system. My long-term vision for an NSERC-funded research program is to define the regulatory mechanisms that govern lipid handling in the gut and to determine how they are integrated with systemic biology. Dietary fats are digested and taken up by gut absorptive cells (enterocytes). In the enterocyte, the majority of absorbed fats are packaged into lipoprotein particles that are secreted from the cells to deliver energy to the body. A portion of the dietary fats form cytoplasmic lipid droplets (CLDs) in the enterocytes. CLDs are intracellular organelles that have diverse biological functions, abnormalities of which are linked to cellular stresses. CLDs are mobilized through lipolysis to release fatty acids that are directed to lipoprotein secretion or other essential cellular functions. Being able to control CLD mobilization and to partition fatty acids among various biological needs is essential for maintaining both local and systemic functions. However, to date, very little is known about the regulation of CLD mobilization and metabolic fates in gut enterocytes. My short-term goal during this 5-year NSERC-funded program is to systemically identify and characterize molecular mediators of lipid metabolism in gut enterocytes. I plan to build upon my strong expertise in gut lipid metabolism and my most recent findings, using innovative and integrative approaches, to 1) examine CLD dynamics, 2) identify proteins and phospholipids that mediate CLD mobilization, and 3) elucidate the functional roles of proteins that regulate CLD mobilization. Experiments will be carried out in an animal model I have successfully established. CLDs will be analyzed with imaging. Proteins and phospholipids in whole enterocytes, intracellular organelles (CLDs, endoplasmic reticulum), and secreted products will be analyzed with proteomics and lipidomics. The role of candidate and newly identified proteins will be examined in vivo with protein inhibitors. This program offers cutting-edge HQP training opportunities, as well as enriching intellectual environment for making discoveries that improve our understanding of a fundamental aspect of biological system. Findings from these studies will not only reveal how lipids are trafficked and partitioned among multiple cellular functions, but also open opportunities for mitigating cellular stresses. Considering the nutritional and environmental stresses faced by modern society, such advancements in knowledge may help develop novel coping strategies and improve the overall wellbeing of mammalian life.
大多数哺乳动物以膳食脂肪作为主要的能量来源。肠道对膳食脂肪的处理在全身能量稳态和生理中起着至关重要的作用,对身体其他部位和整个系统有着深远的影响。我对nserc资助的研究项目的长期愿景是定义控制肠道脂质处理的调节机制,并确定它们如何与系统生物学相结合。膳食脂肪被肠道吸收细胞(肠细胞)消化和吸收。在肠细胞中,大部分被吸收的脂肪被包装成脂蛋白颗粒,由细胞分泌,向身体输送能量。部分膳食脂肪在肠细胞内形成细胞质脂滴(CLDs)。CLDs是具有多种生物学功能的胞内细胞器,其异常与细胞应激有关。cld通过脂肪分解被动员,释放脂肪酸,这些脂肪酸直接用于脂蛋白分泌或其他必需的细胞功能。能够控制CLD的动员和在各种生物需求中分配脂肪酸是维持局部和全身功能所必需的。然而,迄今为止,我们对肠道细胞中CLD动员和代谢命运的调控知之甚少。在这个为期5年的nserc资助项目中,我的短期目标是系统地识别和表征肠道细胞中脂质代谢的分子介质。我计划利用我在肠道脂质代谢方面的强大专业知识和我最近的发现,使用创新和综合的方法,1)检查CLD动力学,2)鉴定介导CLD动员的蛋白质和磷脂,3)阐明调节CLD动员的蛋白质的功能作用。实验将在我成功建立的动物模型上进行。CLDs将通过成像进行分析。用蛋白质组学和脂质组学分析整个肠细胞、胞内细胞器(CLDs、内质网)和分泌产物中的蛋白质和磷脂。候选蛋白和新发现的蛋白的作用将在体内用蛋白抑制剂进行检测。该计划提供尖端的HQP培训机会,以及丰富的知识环境,使发现能够提高我们对生物系统基本方面的理解。这些研究结果不仅揭示了脂质是如何在多种细胞功能中运输和分配的,而且还为减轻细胞压力提供了机会。考虑到现代社会所面临的营养和环境压力,这些知识的进步可能有助于开发新的应对策略,并改善哺乳动物生活的整体健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xiao, Changting其他文献
Glucagon-Like Peptide-2 Regulates Release of Chylomicrons From the Intestine
- DOI:
10.1053/j.gastro.2014.08.037 - 发表时间:
2014-12-01 - 期刊:
- 影响因子:29.4
- 作者:
Dash, Satya;Xiao, Changting;Lewis, Gary F. - 通讯作者:
Lewis, Gary F.
Intranasal Insulin Suppresses Endogenous Glucose Production in Humans Compared With Placebo in the Presence of Similar Venous Insulin Concentrations
- DOI:
10.2337/db14-0685 - 发表时间:
2015-03-01 - 期刊:
- 影响因子:7.7
- 作者:
Dash, Satya;Xiao, Changting;Lewis, Gary F. - 通讯作者:
Lewis, Gary F.
Glucose and GLP-2 (Glucagon-Like Peptide-2) Mobilize Intestinal Triglyceride by Distinct Mechanisms
- DOI:
10.1161/atvbaha.119.313011 - 发表时间:
2019-08-01 - 期刊:
- 影响因子:8.7
- 作者:
Stahel, Priska;Xiao, Changting;Lewis, Gary F. - 通讯作者:
Lewis, Gary F.
High-Dose Resveratrol Treatment for 2 Weeks Inhibits Intestinal and Hepatic Lipoprotein Production in Overweight/Obese Men
- DOI:
10.1161/atvbaha.113.302342 - 发表时间:
2013-12-01 - 期刊:
- 影响因子:8.7
- 作者:
Dash, Satya;Xiao, Changting;Lewis, Gary F. - 通讯作者:
Lewis, Gary F.
C-Reactive Protein Impairs Hepatic Insulin Sensitivity and Insulin Signaling in Rats: Role of Mitogen-Activated Protein Kinases
- DOI:
10.1002/hep.24011 - 发表时间:
2011-01-01 - 期刊:
- 影响因子:13.5
- 作者:
Xi, Liang;Xiao, Changting;Lewis, Gary F. - 通讯作者:
Lewis, Gary F.
Xiao, Changting的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xiao, Changting', 18)}}的其他基金
Regulation of Cytoplasmic Lipid Droplet Mobilization in Intestinal Enterocyte
肠肠上皮细胞胞质脂滴动员的调节
- 批准号:
DGECR-2021-00491 - 财政年份:2021
- 资助金额:
$ 2.7万 - 项目类别:
Discovery Launch Supplement
Regulation of Cytoplasmic Lipid Droplet Mobilization in Intestinal Enterocyte
肠肠上皮细胞胞质脂滴动员的调节
- 批准号:
RGPIN-2021-03608 - 财政年份:2021
- 资助金额:
$ 2.7万 - 项目类别:
Discovery Grants Program - Individual
相似海外基金
Regulation of Cytoplasmic Lipid Droplet Mobilization in Intestinal Enterocyte
肠肠上皮细胞胞质脂滴动员的调节
- 批准号:
DGECR-2021-00491 - 财政年份:2021
- 资助金额:
$ 2.7万 - 项目类别:
Discovery Launch Supplement
Regulation of Cytoplasmic Lipid Droplet Mobilization in Intestinal Enterocyte
肠肠上皮细胞胞质脂滴动员的调节
- 批准号:
RGPIN-2021-03608 - 财政年份:2021
- 资助金额:
$ 2.7万 - 项目类别:
Discovery Grants Program - Individual
Mechanisms of cytoplasmic lipid droplet regulation in the intestine
肠道细胞质脂滴调节机制
- 批准号:
9244666 - 财政年份:2016
- 资助金额:
$ 2.7万 - 项目类别:
Mechanisms of cytoplasmic lipid droplet regulation in the intestine
肠道细胞质脂滴调节机制
- 批准号:
9121995 - 财政年份:2016
- 资助金额:
$ 2.7万 - 项目类别:
DEVELOPMENTAL REGULATION OF CYTOPLASMIC LIPID DROPLET SYNTHESIS
细胞质脂滴合成的发育调控
- 批准号:
7018032 - 财政年份:2005
- 资助金额:
$ 2.7万 - 项目类别:
Developmental Regulation of Cytoplasmic Lipid Droplet Synthesis
细胞质脂滴合成的发育调控
- 批准号:
8511744 - 财政年份:
- 资助金额:
$ 2.7万 - 项目类别:
DEVELOPMENTAL REGULATION OF CYTOPLASMIC LIPID DROPLET SYNTHESIS
细胞质脂滴合成的发育调控
- 批准号:
7634422 - 财政年份:
- 资助金额:
$ 2.7万 - 项目类别:
Developmental Regulation of Cytoplasmic Lipid Droplet Synthesis
细胞质脂滴合成的发育调控
- 批准号:
8212844 - 财政年份:
- 资助金额:
$ 2.7万 - 项目类别:
Developmental Regulation of Cytoplasmic Lipid Droplet Synthesis
细胞质脂滴合成的发育调控
- 批准号:
8379425 - 财政年份:
- 资助金额:
$ 2.7万 - 项目类别:
DEVELOPMENTAL REGULATION OF CYTOPLASMIC LIPID DROPLET SYNTHESIS
细胞质脂滴合成的发育调控
- 批准号:
7849685 - 财政年份:
- 资助金额:
$ 2.7万 - 项目类别: